Stock Track | JD Health Soars 5.11% in Pre-Market on Strong Q1 Earnings and $1 Billion Share Buyback Plan

Stock Track05-13

JD Health's stock surged 5.11% in pre-market trading on Wednesday, driven by the company's robust first-quarter financial results and a newly announced share repurchase program.

The company reported Q1 revenue of RMB 19.468 billion, a 17% year-over-year increase, while operating profit jumped 70.4% to RMB 1.825 billion. On a non-IFRS basis, operating profit rose 48% to RMB 1.94 billion. Additionally, JD Health's board approved a plan to repurchase up to $1 billion worth of shares over the next 48 months, signaling strong confidence in the company's long-term value.

Business developments also contributed to positive sentiment, including the launch of over 30 new drugs, strategic partnerships with major pharmaceutical firms, and significant growth in AI-driven medical services, with user numbers already surpassing the full-year total from the prior year.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment